Operating Expenses 更改
AbbVie USD 11.11B 540M 2023-12
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Celldex Therapeutics USD 51.76M 9M 2023-12
CSL USD 5.19B 142.6M 2023-06
Dynavax Technologies USD 64.09M 311K 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Incyte USD 826.07M 121.75M 2023-12
Merck EUR 4.19B 143M 2023-09
Merck USD 16.56B 6.35B 2023-12
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Veracyte USD 133.71M 11.86M 2023-12



Agenus 营业费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Apr 2024.